Phillips Medisize

Recently in Medical Product Outsourcing, David Wolgemuth and Griffin Doak were featured in the article “An Automatic Advantage for Medical Device Manufacturers.” The article discusses advancements in AI, robotics and machine vision systems, and how these advancements are helping medtech firms scale operations efficiently and manage the complexities of advanced device designs. Read the full article here: https://lnkd.in/ez-gugPU #ManufacturingTechnology #CDMO #PhillipsMedisize

Join Phillips Medisize at PDA 2025! We’re excited to exhibit at PDA - Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference 2025, where pharmaceutical industry leaders come together to drive innovation in drug delivery and manufacturing. Visit us at Booth 26 to discover our advanced drug delivery solutions and scalable manufacturing capabilities. On October 21, 4:30–4:45 p.m. (CET), don’t miss the presentation by Gemma Wood, MBA, CMgr, Director – Platform Management, and Amanda Tilles, Human Factors Manager, on “A Study of Factors Impacting User Perceptions of Reusable and Disposable Autoinjectors.” Want to connect with our team during the event? Learn more: https://lnkd.in/esYhQn8k #PDAUniverse2025 #StudyDesign #DrugDelivery #PhillipsMedisize

How to Ask Better Questions: Cracking the Code of Preference Through Study Design At PDA - Parenteral Drug Association Universe 2025, we’re excited to offer a deeper look into the methodology behind our recent research on autoinjector user preferences. This Tech Talk goes beyond the “what” to uncover the “why” — revealing how thoughtful study design can decode the deeper motivations that drive device adoption decisions. Join our co-presenters, Kaylene Kau, Senior UX Designer, and Amanda Tilles, Human Factors Engineering Manager, on Wednesday, October 22, as they share practical strategies to design studies that get to the heart of user preferences. Learn more about our approach to solving complex problems — through listening and asking insight-driven questions: https://lnkd.in/e99EcBMC #PDAUniverse2025 #UserResearch #StudyDesign #DrugDelivery #PhillipsMedisize #PatientExperience #Innovation

Engineering Expertise from Discovery to Delivery A collaboration with our R&D team focuses on reducing risk, maximizing investment returns and achieving launch timelines within the complexity of the pharma, medtech and IVD device industries. Learn more about how our engineers offer a complete range of capabilities, services and expertise to help our customers achieve their unique design, development and manufacturing needs: https://lnkd.in/exGTBnWN #Engineering #ResearchandDevelopment #PhillipsMedisize #CDMO

It was a great first day at the Medical Technology Ireland conference. We are excited to continue discussing the latest in medtech innovation, medical device design and manufacturing tomorrow! Visit us at booth #111 and discover how our expertise spans from human factors engineering and design for manufacturing (DfM) to supply chain management and sterilization. We’re ready to help you innovate at every stage of your product’s journey. Explore our capabilities and find out more about our participation at the Medical Technology Ireland Expo and Conference by visiting our website: https://lnkd.in/ek7AUVNy #MedTech #MedtechIreland #PhillipsMedisize

Great to meet so many customers and colleagues at the Medical Technology Ireland Show in Galway. Phillips Medisize

Exploring User Perceptions of Autoinjectors at PDA Universe 2025 Join our co-presenters, Gemma Wood, MBA, CMgr, Director, Platform Management, and Amanda Tilles, Human Factors Engineering Manager, as they present “A Study of Factors Impacting User Perceptions of Reusable and Disposable Autoinjectors,” at the upcoming PDA - Parenteral Drug Association Universe of Pre-Filled Syringes and Injection Devices Conference on Tuesday, October 21. This research explores how patients and healthcare professionals perceive the ease of use and overall preference of different autoinjector types — including single-use disposable, reusable electromechanical and reusable mechanical devices — and how exposure influences their preferences. We look forward to connecting with peers and advancing conversations around user-centric innovation in drug delivery! Learn more about our presence at PDA: https://lnkd.in/eCkyaeQf PDA - Parenteral Drug Association #PDAUniverse2025 #Autoinjectors #DrugDelivery #HumanFactors #PhillipsMedisize #Innovation #PatientExperience

As head of our Pharma business, Vivek Malhotra leads a global team to collaborate and deliver to our pharmaceutical customers wherever they are. “I am inspired by how we bring our capabilities, culture and people together to impact lives. It is a privilege to help lead these efforts and contribute to health worldwide.” Vivek Malhotra, Vice President, Global Pharma Discover your potential to make a difference! https://lnkd.in/eW-EnzJz #Careers #PhillipsMedisize #BringingPossibilitiestoLife

We were pleased to participate in PDA - Parenteral Drug Association Japan, where our Chief Scientific Officer & EVP TS&I Dr. Geraldine Venthoye delivered an insightful seminar titled “Key Considerations When Repositioning from Parenteral to Inhaled Drug Administration.” The presentation explored critical factors in transitioning drug delivery methods to better meet patient needs, highlighting challenges and opportunities in inhaled therapeutics development. If you missed the presentation or have questions about this important topic, we invite you to reach out to us directly: https://lnkd.in/eyZBjFAy We look forward to continuing the conversation and driving innovation in drug delivery solutions. #PDAJapan #DrugDelivery #InhalationTherapy #PhillipsMedisize

Expanding Therapeutic Targets for Injection and Inhalation Our Chief Scientific Officer, Geraldine Venthoye, recently joined Tom von Gunden on the Supplier Horizons webcast to discuss evolving approaches in drug delivery within Healthcare 5.0. She examined the formulation and delivery challenges of novel therapeutics including complex biologics—such as vaccines, immunotherapies, and cell and gene therapies—highlighting opportunities for higher payload delivery systems including developments in autoinjectors to handle higher viscosity and volume and dry powder inhalers delivering higher doses. Geraldine also shared insights on the growing potential for patient-friendly, portable, self-administered devices that could support more flexible care settings beyond traditional hospitals. Watch the full discussion or read the transcript here: https://lnkd.in/e8brX5yn #DrugDelivery #HealthcareInnovation #PhillipsMedisize #BringingPossibilitiestoLife